MaaT Pharma, building on INRA’s research, was recognised at the Worldwide Innovation Challenge and received its award on 17 September in the presence of the President of France, François Hollande. MaaT Pharma’s project deals with treating severe intestinal microbiota disorders, in various clinical settings, with innovative technologies making use of microbiotherapy.
